UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity

Cell reports (Cambridge), 2024-10, Vol.43 (10), p.114834, Article 114834

2024

Volltextzugriff (PDF)

Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants

The Journal of infection, 2024-10, Vol.89 (4), p.106246, Article 106246

2024

Volltextzugriff (PDF)

Expansion of phenotypically modified type 2 memory B cells after allergen immunotherapy

Allergy (Copenhagen), 2024-09

2024

Volltextzugriff (PDF)

Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring

Ocular immunology and inflammation, 2024-09, Vol.ahead-of-print (ahead-of-print), p.1-6

2024

Volltextzugriff (PDF)

Subcutaneous immunotherapy for bee venom allergy induces epitope spreading and immunophenotypic changes in allergen-specific memory B cells

Journal of allergy and clinical immunology, 2024-08

2024

Volltextzugriff (PDF)

A recent patent in allergy & immunology: Biomarkers on allergen‐specific memory B cells to predict allergen immunotherapy outcome

Allergy (Copenhagen), 2024-08, Vol.79 (8), p.2295-2297

2024

Volltextzugriff (PDF)

Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding

npj vaccines, 2024-07, Vol.9 (1), p.129-11, Article 129

2024

Volltextzugriff (PDF)

An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity

Vaccines (Basel), 2024-06, Vol.12 (6), p.675

2024

Volltextzugriff (PDF)

Accurate determination of house dust mite sensitization in asthma and allergic rhinitis through cytometric detection of Der p 1 and Der p 2 binding on basophils (CytoBas)

Journal of allergy and clinical immunology, 2024-05, Vol.153 (5), p.1282-1291.e10

2024

Volltextzugriff (PDF)

IgE in allergy: It takes two

Science translational medicine, 2024-02, Vol.16 (733), p.eadl1202

2024

Volltextzugriff (PDF)

Serological responses and clinical outcomes following a three-dose primary COVID-19 vaccine schedule in kidney transplant recipients and people on dialysis

Clinical & translational immunology, 2024-01, Vol.13 (7), p.e1523-n/a

2024

Volltextzugriff (PDF)

Mechanisms and Predictive Biomarkers of Allergen Immunotherapy in the Clinic

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2024-01, Vol.12 (1), p.59-66

2024

Volltextzugriff (PDF)

A case of primary ciliary dyskinesis with DRC1 deletion and literature review: Additional evidence on the founder effect

Pediatrics international, 2024-01, Vol.66 (1), p.e15808

2024

Volltextzugriff (PDF)

COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants

Journal of clinical immunology, 2023-10, Vol.43 (7), p.1506-1518

2023

Volltextzugriff (PDF)

TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies

Journal of allergy and clinical immunology, 2023-09, Vol.152 (3), p.736-747

2023

Volltextzugriff (PDF)

Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants

Journal of allergy and clinical immunology, 2023-09, Vol.152 (3), p.807-813.e7

2023

Volltextzugriff (PDF)

Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells

Frontiers in immunology, 2023-07, Vol.14, p.1165936-1165936

2023

Volltextzugriff (PDF)

Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet

Allergy (Copenhagen), 2023-07, Vol.78 (7), p.2040-2043

2023

Volltextzugriff (PDF)

Anti-tissue transglutaminase antibodies (TG2A) positivity and the risk of vitamin D deficiency among children - a cross-sectional study in the generation R cohort

BMC pediatrics, 2023-06, Vol.23 (1), p.286-286, Article 286

2023

Volltextzugriff (PDF)

Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan

Journal of clinical immunology, 2023-04, Vol.43 (3), p.585-594

2023

Volltextzugriff (PDF)

The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2

Allergy (Copenhagen), 2023-03, Vol.78 (3), p.855-858

2023

Volltextzugriff (PDF)

RNA sequencing of single allergen‐specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect

Allergy (Copenhagen), 2023-03, Vol.78 (3), p.822-835

2023

Volltextzugriff (PDF)

The second COVID ‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA .2

Allergy (Copenhagen), 2023-03, Vol.78 (3), p.855-858

2023

Volltextzugriff (PDF)

Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling

Molecular immunology, 2023-03, Vol.155, p.124-134

2023

Volltextzugriff (PDF)

Multiple sclerosis risk variants influence the peripheral B‐cell compartment early in life in the general population

European journal of neurology, 2023-02, Vol.30 (2), p.434-442

2023

Volltextzugriff (PDF)

1 – 25 von 205

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(189)

Publikationsform

Sprache

Englisch
(203)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity

Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants

Expansion of phenotypically modified type 2 memory B cells after allergen immunotherapy

Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring

Subcutaneous immunotherapy for bee venom allergy induces epitope spreading and immunophenotypic changes in allergen-specific memory B cells

A recent patent in allergy & immunology: Biomarkers on allergen‐specific memory B cells to predict allergen immunotherapy outcome

Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding

An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity

Accurate determination of house dust mite sensitization in asthma and allergic rhinitis through cytometric detection of Der p 1 and Der p 2 binding on basophils (CytoBas)

IgE in allergy: It takes two

Serological responses and clinical outcomes following a three-dose primary COVID-19 vaccine schedule in kidney transplant recipients and people on dialysis

Mechanisms and Predictive Biomarkers of Allergen Immunotherapy in the Clinic

A case of primary ciliary dyskinesis with DRC1 deletion and literature review: Additional evidence on the founder effect

COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants

TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies

Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants

Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells

Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet

Anti-tissue transglutaminase antibodies (TG2A) positivity and the risk of vitamin D deficiency among children - a cross-sectional study in the generation R cohort

Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan

The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2

RNA sequencing of single allergen‐specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect

The second COVID ‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA .2

Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling

Multiple sclerosis risk variants influence the peripheral B‐cell compartment early in life in the general population

Suchergebnisse filtern